SUMMARY Two different beta-adrenoreceptor antagonists, atenolol and timolol, were separately compared with a placebo in the suppression of essential tremor. In two-week single-blind placebo-controlled studies with cross-over, timolol (5 mg twice daily) and atenolol (100 mg once daily) produced an equal reduction in sitting heart rate and sitting blood pressure. Timolol was effective in reducing tremor while atenolol failed to reduce tremor amplitude. These results indicate that essential tremor can be reduced but not blocked, by the adrenergic blocker timolol with both /31 and /32 blocking properties; but not by the relatively selective /81 blocking drug atenolol. Possibly, the tremor reduction is mediated by a peripheral effect on /32 adrenoreceptors. 
The use of propranolol is now an established method for reducing the amplitude of benign essential tremor.-1-6 However, coexisting chronic dbstructive bronchitis is not uncommon in patients with tremor and can prevent the use of this drug. Furthermore, hypotension can be a serious sideeffect of propranolol treatment.7 This makes it desirable to find out whether some other , 8 
Methods
The effects on tremor of (A) a period on timolol against a period on placebo and (B) a period on atenolol against a period on placebo were separately studied. The periods were of one week (7 which is the wanted parameter (right row, arrow).
Results
The amount of tremor in each patient was assessed at five stages of the two weeks study (fig 1, arrows) , then the values were mutually compared and the differences estimated by using the two-tailed Wilcoxon signed rank test.'2 The main frequencies ranged between 5 6-9 9 Hz and were unchanged during the study. In the present study, essential tremor was reduced but not blocked by the beta-adrenoreceptor antagonist timolol exerting both 181 and 132 blocking properties, but not by the predominantly 181 blocking drug atenolol. The reduction of tremor amplitude by the water soluble timolol, is apparently not related to its poor penetration into the brain. These findings suggest an important peripheral 12 mechanism which determines the amplitude of essential tremor. However, another possibility is that the reduction of tremor, is the result of some active metabolite of the drug and not to the drug itself.
